The report also said 98 percent of wholesale distributors’ net sales came from pharmaceutical product distribution, but the product mix is shifting. Branded pharmaceutical sales have decreased to 76 percent, but branded specialty pharmaceutical products increased to 13.5 percent of those sales.
The report also found generic drug sales are up eight percent from 2009, and they now represent 8.3 percent of total distributor sales.
Related Articles About the Pharmaceutical Industry:
Funding Cutbacks, Complex Device Approval Process Threaten Med Tech Industry
Survey: Venture Capitalists Moving Away from Medical Device and Pharmaceutical Companies
FDA Grants NIPTE $35 Million to Reform Drug Manufacturing Process
